The Latest
FDA Approval Updates Enjaymo Indication for Cold Agglutinin Disease
Keytruda Approved as Adjuvant Treatment for Stage IB, II, or IIIA NSCLC
Bivalent Vaccine Provides Added Protection Against BA.5, XBB/XBB.1.5
CDC Reports on Prevalence of Seasonal and Food Allergies, Eczema
FDA Revises Evusheld EUA Halting Use of the COVID-19 Therapy for Now
Abbott’s SCS System Cleared for Patients With Painful Diabetic Peripheral Neuropathy
Trial Evaluating Lisocabtagene Maraleucel for Relapsed/Refractory CLL Meets Endpoint
Briumvi Now Available for Multiple Sclerosis Treatment
Sleep Medication Used by 8.4% of Adults in 2020
Get the latest news in our COVID-19 Resource Center.MPR ARTICLES
